Chromogranin A Regulates Renal Function by Triggering Weibel–Palade Body Exocytosis
Author(s) -
Yuqing Chen,
Manjula Mahata,
Fangwen Rao,
Srikrishna Khandrika,
Maïté Courel,
Maple M. Fung,
Kuixing Zhang,
Mats Stridsberg,
Michael G. Ziegler,
Bruce A. Hamilton,
Michael S. Lipkowitz,
Laurent Taupenot,
Caroline M. Nievergelt,
Sushil K. Mahata,
Daniel T. O’Connor
Publication year - 2009
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2008111148
Subject(s) - chromogranin a , exocytosis , endocrinology , medicine , umbilical vein , endothelium , secretion , kidney disease , endothelin receptor , biology , in vitro , receptor , immunohistochemistry , genetics
Chromogranin A (CHGA), a protein released from secretory granules of chromaffin cells and sympathetic nerves, triggers endothelin-1 release from endothelial cells. CHGA polymorphisms associate with an increased risk for ESRD, but whether altered CHGA-endothelium interactions may explain this association is unknown. Here, CHGA led to the release of endothelin-1 and Weibel-Palade body exocytosis in cultured human umbilical vein endothelial cells. In addition, CHGA triggered secretion of endothelin-1 from glomerular endothelial cells and TGF-beta1 from mesangial cells cocultured with glomerular endothelial cells. In humans, plasma CHGA correlated positively with endothelin-1 and negatively with GFR. GFR was highly heritable in twin pairs, and common promoter haplotypes of CHGA predicted GFR. In patients with progressive hypertensive renal disease, a CHGA haplotype predicted rate of GFR decline. In conclusion, these data suggest that CHGA acts through the glomerular endothelium to regulate renal function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom